Background Clinical practice guidelines （CPGs） play an important role in healthcare in China as well as in the world. However, the current status and trends of Chinese CPGs are unknown. The aim of this study was to ...Background Clinical practice guidelines （CPGs） play an important role in healthcare in China as well as in the world. However, the current status and trends of Chinese CPGs are unknown. The aim of this study was to systematically review the present situation and the quality of Chinese CPGs published in the peer-reviewed medical literature. Methods To identify Chinese CPGs, a systematic search of relevant literature databases （CBM, WANFANG, VIP, and CNKI） was performed for the period January 1978 to December 2010. We used the AGREE II instrument to assess the quality of the included guidelines. Results We evaluated 269 guidelines published in 115 medical journals from 1993 to 2010 and produced by 256 different developers. Only four guidelines （1%） described the systematic methods for searching and selecting the evidence, 14 （5%） guidelines indicated an explicit link between the supporting evidence and the recommendations, only one guideline used the Grading of Recommendations Assessment, Development and Evaluation （GRADE） system. Thirty-one guidelines （12%） mentioned updates and the average frequency of update was 5.5 years; none described a procedure for updating the guideline. From the assessment with the Appraisal of Guidelines for Research and Ecaluation II （AGREE II）, the mean scores were low for the domains ＂scope and purpose＂ （19%） and ＂clarity of presentation＂ （26%） and very low for the other domains （＂rigour of development＂ 7%, ＂stakeholder involvement＂ 8%, ＂applicability＂ 6% and ＂editorial independence＂ 2%）. Conclusions Compared with other studies on the quality of guidelines assessed with the AGREE instrument in other countries, Chinese CPGs received lower scores, which indicates a relatively poor quality of the guidelines. However, there was some increase over time.展开更多
目的:探究葛根素注射液所致不良反应(adverse drug reactions,ADR)的规律和特点,为临床合理用药提供参考。方法:通过检索2001—2013年国内医学期刊,以及浙江省药品不良反应监测中心接收到的葛根素注射液不良反应报告,共325例进行分析和...目的:探究葛根素注射液所致不良反应(adverse drug reactions,ADR)的规律和特点,为临床合理用药提供参考。方法:通过检索2001—2013年国内医学期刊,以及浙江省药品不良反应监测中心接收到的葛根素注射液不良反应报告,共325例进行分析和总结。结果:葛根素注射液的不良反应临床表现主要为药物热、药疹、溶血及休克等症状,在高剂量(≥400 mg/d)及连续用药时更易发生。结论:葛根素注射液不良反应的发生与多种因素有关,应用时应高度警惕。展开更多
文摘Background Clinical practice guidelines （CPGs） play an important role in healthcare in China as well as in the world. However, the current status and trends of Chinese CPGs are unknown. The aim of this study was to systematically review the present situation and the quality of Chinese CPGs published in the peer-reviewed medical literature. Methods To identify Chinese CPGs, a systematic search of relevant literature databases （CBM, WANFANG, VIP, and CNKI） was performed for the period January 1978 to December 2010. We used the AGREE II instrument to assess the quality of the included guidelines. Results We evaluated 269 guidelines published in 115 medical journals from 1993 to 2010 and produced by 256 different developers. Only four guidelines （1%） described the systematic methods for searching and selecting the evidence, 14 （5%） guidelines indicated an explicit link between the supporting evidence and the recommendations, only one guideline used the Grading of Recommendations Assessment, Development and Evaluation （GRADE） system. Thirty-one guidelines （12%） mentioned updates and the average frequency of update was 5.5 years; none described a procedure for updating the guideline. From the assessment with the Appraisal of Guidelines for Research and Ecaluation II （AGREE II）, the mean scores were low for the domains ＂scope and purpose＂ （19%） and ＂clarity of presentation＂ （26%） and very low for the other domains （＂rigour of development＂ 7%, ＂stakeholder involvement＂ 8%, ＂applicability＂ 6% and ＂editorial independence＂ 2%）. Conclusions Compared with other studies on the quality of guidelines assessed with the AGREE instrument in other countries, Chinese CPGs received lower scores, which indicates a relatively poor quality of the guidelines. However, there was some increase over time.
文摘目的:探究葛根素注射液所致不良反应(adverse drug reactions,ADR)的规律和特点,为临床合理用药提供参考。方法:通过检索2001—2013年国内医学期刊,以及浙江省药品不良反应监测中心接收到的葛根素注射液不良反应报告,共325例进行分析和总结。结果:葛根素注射液的不良反应临床表现主要为药物热、药疹、溶血及休克等症状,在高剂量(≥400 mg/d)及连续用药时更易发生。结论:葛根素注射液不良反应的发生与多种因素有关,应用时应高度警惕。
